Stage I Multiple Myeloma Treatment (IFM-01-04).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2012
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 23 Mar 2012 Last checked against ClinicalTrials.gov record.
- 23 Mar 2012 Planned end date changed from 1 Nov 2009 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 23 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.